NCT07076667 Effects of Benson's Relaxation and Tai Chi in COPD
| NCT ID | NCT07076667 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | COPD |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2025-07-03 |
| Primary Completion | 2025-11-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2025-07-03 with a primary completion date of 2025-11-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disorder that significantly impacts respiratory function and quality of life. As COPD patients often experience symptoms such as dyspnea, fatigue, and anxiety, non-pharmacological interventions like Benson's Relaxation Technique and Tai Chi are gaining attention for their potential benefits in managing these symptoms.This study aimed to compare the effectiveness of Benson's Relaxation Technique and Tai Chi on improving dyspnea, physical endurance, and quality of life in COPD patients.
Eligibility Criteria
Inclusion Criteria: * Age40 to 50 * Bothmaleandfemale * DiagnosedmoderatetosevereCOPDpatients * Participants must be physicallyable to participate in Tai Chi or Benson relaxation technique * Participantsmustbewillingtoparticipate Exclusion Criteria: * Pulmonaryhypertension * Congenitalheartdisease(recentmyocardialinfarction,unstableangina,or uncontrolled hypertension) * Spinal deformities * Lossof consciousness
Contact & Investigator
Iram Nawaz, Mphill
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07076667 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 50 Years, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07076667 currently recruiting?
Yes, NCT07076667 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07076667 trial being conducted?
This trial is being conducted at Chak Four Hundred Fifty-four, Pakistan.
Who is sponsoring the NCT07076667 clinical trial?
NCT07076667 is sponsored by Riphah International University. The principal investigator is Iram Nawaz, Mphill at Riphah International University. The trial plans to enroll 54 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.